Andrew Brand

Andrew Brand serves as Trial Statistician at Bangor University's North Wales Medical School, previously holding the same role at the university's School of Health Sciences. His research-intensive position focuses on statistical leadership for clinical trials across diverse medical domains, with 36 documented publications spanning 2008-2025.

His research fingerprint reveals dominant expertise in randomized controlled trials (100%), with significant concentrations in early-onset dementia (80%), cognitive rehabilitation (78%), and cost-effectiveness analysis (71%). Additional research threads include neonatal health, stroke rehabilitation, breast cancer in pregnancy, and AI applications in gastroenterology. His methodology work bridges statistical theory with practical healthcare solutions through multicenter collaborations.

Recent publications (2024-2025) demonstrate active engagement in high-impact clinical research, including the BELIDE dementia caregiver trial, CHOSEN stroke rehabilitation study, neonatal noise impact analysis, AI-assisted colonoscopy evaluation, and UK breast cancer in pregnancy registry. These outputs showcase his cross-disciplinary approach to improving healthcare delivery through rigorous trial design and health economics analysis.